Skip to main content

Table 4 Biochemistry results for the nested cohort (n = 1002)

From: Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries

Variable (unit)

Day 1

Day 3

Day 7

Mean (SD)

n (%)

Mean (SD)

n (%)

Mean (SD)

n (%)

Bilirubin (μmol/L)

17.8 (15.0)

995 (99.3)

8.8 (8.0)

994 (99.2)

9.2 (8.1)

1000 (99.8)

ALT (U/L)

28.9 (28.8)

997 (99.5)

27.3 (28.5)

995 (99.3)

27.7 (24.4)

1000 (99.8)

AST (U/L)

31.1 (36.4)

1000 (99.8)

29.0 (30.3)

997 (99.5)

27.9 (21.2)

1001 (99.9)

Creatinine (μmol/L)

52.0 (30.2)

990 (98.8)

53.1 (32.5)

984 (98.2)

50.9 (29.4)

994 (99.2)

Urea (mmol/L)

4.9 (3.9)

997 (99.5)

4.3 (3.9)

983 (98.1)

4.1 (4.1)

998 (99.6)